Seaport Therapeutics, Inc. Common Stock

NASDAQ:SPTX

Biotechnology

Healthcare
$18.31 +0.58%

+$0.10 today

Market cap
$980.14M
Beta
0.00
52W Low $14.85High $23.00

Volume 0.68M

Average 0.41M

SPTX Net Debt

Total debt minus cash and equivalents; a negative value means the company holds more cash than debt.

No reported Net Debt figures are available to summarize.

Net Debt history

Currency unavailable · from the balance sheet

No Net Debt data reported for this period type.

Net Debt vs competitors

How SPTX compares with its peers on the latest reported figures

SPTX Competitors
Net Debt for SPTX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
CTNMContineum Therapeutics, Inc. Class A Common StockMar 2026-$13.2M USD+19.8%—5.1%
VNDAVanda Pharmaceuticals Inc.Mar 2026-$40.96M USD+59.1%—9.4%
MPLTMapLight Therapeutics, Inc.Mar 2026-$50.12M USD-14.5%—12.0%
RAPPRapport Therapeutics, Inc. Common StockMar 2026-$67.25M USD-35.1%—13.5%
NMRANeumora Therapeutics, Inc. Common StockMar 2026-$146.66M USD-16.5%—95.3%
GHRSGH Research PLCMar 2026-$242.22M USD+0.8%—88.0%
LBRXLB Pharmaceuticals Inc Common StockMar 2026-$317.21M USD-2931.4%—80.6%
SPTXSeaport Therapeutics, Inc. Common Stock—— ———
Peer median (excluding SPTX) —-14.5%—13.5%

Competitors are the stored peer set for SPTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Seaport Therapeutics, Inc. Common Stock

NASDAQ:SPTX

Intrinsic Alpha fair value

Locked

Current Price

$18.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.